FDA clearances, society guidelines, and device launches across dermatology.
The FDA added knee skin laxity to Ulthera's US indications in May 2026. Read what changed, what the small studies show, and questions to ask a clinician.
The FDA added bemotrizinol to the OTC sunscreen monograph in June 2026. What the order allows, what absorption and stability data show, and what is unknown.
An emerging dermatophyte species is poorly responsive to terbinafine and cannot be identified without molecular testing. What the resistance data show and what they change in practice.
The FDA received reports of serious complications with certain RF microneedling uses in 2025. Learn what was reported, remains unknown, and how needling differs.
The World Federation for Ultrasound in Medicine and Biology (WFUMB) released 24 consensus recommendations standardizing dermatologic ultrasound for aesthetic procedures: what changed and what it means for practice.